Table 1 Drug treatment at discharge after index AMI. Patients stratified by age (≤75 years or 75–84 years) and by PCI status (PCI or no PCI)
Age ≤75 years | Age 75–84 years | Total | |||
|---|---|---|---|---|---|
n = 30 843 | n = 11 864 | n = 42 707 | |||
PCI | No PCI | PCI | No PCI | ||
n = 19 835 | n = 11 008 | n = 4918 | n = 6946 | ||
(64.3) | (35.7) | (29.3) | (70.7) | ||
Women | 4065 (20.5) | 3478 (31.6) | 1819 (37.0) | 3357 (48.3) | 12 719 (29.8) |
Age, mean (SD) | 59.8 (9.1) | 61.6 (9.6) | 79.0 (2.8) | 80.0 (2.8) | 65.8 (11.8) |
DAPT | 17 505 (88.3) | 5107 (46.4) | 3877 (78.8) | 2597 (37.4) | 29 086 (68.1) |
Only P2Y12 inhibitor | 668 (3.4) | 354 (3.2) | 202 (4.1) | 295 (4.3) | 1519 (3.6) |
Only ASA | 288 (1.5) | 3105 (28.2) | 151 (3.1) | 1860 (26.7) | 5404 (12.3) |
Only OAC | 21 (0.1) | 312 (2.8) | 15 (0.3) | 339 (4.9) | 687 (1.6) |
OAC + DAPT | 925 (4.7) | 241 (2.2) | 473 (9.6) | 165 (2.4) | 1804 (4.2) |
OAC + P2Y12 inhibitor | 58 (0.3) | 40 (0.4) | 28 (0.6) | 58 (0.8) | 184 (0.4) |
OAC + ASA | 43 (0.2) | 520 (4.7)) | 32 (0.7) | 529 (7.6) | 1124 (2.6) |
No antiplatelet or OAC | 327 (1.7) | 1329 (12.1) | 140 (2.9) | 1103 (15.9) | 2899 (6.8) |
Statins | 19 168 (96.6) | 9224 (83.8) | 4574 (93.0) | 5262 (75.7) | 38 228 (89.5) |
Beta-blockers | 16 763 (84.5) | 8529 (77.5) | 4238 (86.2) | 5456 (78.6) | 34 986 (81.9) |
ACE inhibitors | 7977 (40.3) | 3478 (31.7) | 2027 (41.2) | 2497 (36.0) | 15 988 (37.4) |
ARB | 4822 (24.3) | 2945 (26.8) | 1597 (32.5) | 2072 (29.8) | 11 346 (26.8) |